Research Brief: Genetic Testing for Hereditary Cancers Craig Morse BIO 101 SNHU.

Slides:



Advertisements
Similar presentations
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
Advertisements

†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
10 November 2011 Genetic counseling for breast cancer risk Aichu Huang, MS. CGC. Department of Medical Genetics National Taiwan University Hospital.
Alzheimer disease Developed by Dr. June Carroll, Ms. Shawna Morrison and Dr. Judith Allanson Last updated April 2015.
Hereditary Factors in Breast Cancer
Breast Cancer Risk and Risk Assessment Models
Genetic Susceptibility Risk Models in Clinical Decision Making Susan M. Domchek, MD Abramson Cancer Center University of Pennsylvania.
YOLANDA LAWSON M.D., F.A.C.O.G MADEWELL OBGYN ASSOCIATE ATTENDING BAYLOR UNIVERSITY MEDICAL CENTER Women's Health Screening Guidelines.
Type Of Cancer:Location: CarcinomaEpithelial Cells SarcomaConnective Tissue LeukemiaCirculatory / Lymphatic.
Clinical Solutions for Lung Cancer Screening (LCS)
Tobacco Cessation and Private Insurance under ACA: New Opportunities for Public Health September 25, 2014.
The Harvard Health Caucus Genetic Privacy: Legal & Ethical Frameworks Allan T. Bombard, MD, FACOG, FACS, FACMG Medical Director, Aetna Women’s Health Program.
Breast Cancer Detection, Treatment, and Survival in Medicare and Medicaid Insured Patients Cathy J. Bradley, Ph.D. Professor of Health Administration Co-leader,
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Practice Guidelines The Good, The Not-So-Good The Ugly 1.
Tobacco Cessation and the Affordable Care Act Jennifer Singleterry Director, National Health Policy American Lung Association.
Improving Preventive Health Care for Older Americans Marcel Salive, MD, MPH, FACPM Division of Geriatrics and Clinical Gerontology, NIA.
Title: Presenters: Date: Proportion of Newly Diagnosed Non-Small Cell Lung Cancer Patients That Would Have Been Eligible for Lung Cancer Screening Division.
Prevention and Early Detection of Breast Cancer: Weighing the Risks and Benefits Kathy J. Helzlsouer, M.D., M.H.S. Prevention and Research Center, Women’s.
Clinical Utility of BRCA Testing Mark Robson, MD September 7,
Preventive Health Services Under the Affordable Care Act: Translating Law Into Coverage Naomi Seiler, JD Associate Research Professor George Washington.
Nebraska Breast Cancer Control Partnership Network Strengthening relationships, sharing resources and celebrating successes
Breast cancer screening Diana Sarfati Director, Cancer Control and Screening Research Group.
Medicare Preventive Services Marcel Salive, MD, MPH, FACPM Coverage and Analysis Group, OCSQ Director, Division of Medical and Surgical Services.
Ovarian Cancer Risk Reduction Taking oral contraceptives for 5 years can reduce your risk of ovarian cancer by up to 50% Hankinson SE, Colditz GA, Hunter.
Population Management Breast Cancer Screening October 2013.
Familial cancer syndromes: Tools that can help connect the dots in primary care Emily Edelman, MS, CGC NCHPEG Cancer in the family: Primary Care Matters.
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
Alzheimer disease Developed by Dr. June Carroll, Ms. Shawna Morrison and Dr. Judith Allanson Last updated Dec 2014.
Talking to Your Family About Your Diagnosis of Hereditary Breast and Ovarian Cancer Syndrome Several of my aunts died of breast cancer, so I was very worried.
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
[Insert Organization Name] Making the Case for Lung Cancer Screening.
The US Preventive Services Task Force: Potential Impact on Medicare Coverage Ned Calonge, MD, MPH Chair, USPSTF.
The ACA and Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) Implications for Tobacco Cessation Therapies Steve Melek, FSA, MAAA February.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
Date of download: 5/31/2016 From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation.
Depression Screening in Primary Care and Impact on Suicide Prevention Anne-Marie T. Mann, BSN, RN, DNP Candidate Diane Kay Boyle, PhD, RN, FAAN.
Bleyer Policy Implications Institute of Medicine Washington, DC July 15, 2013 Benefit of Patient Protection and Affordable Care Act (ACA) on AYAs Archie.
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Health Promotion and Screening WOMEN’S HEALTHCARE: DIAGNOSIS AND MANAGEMENT.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Hereditary Cancer Predisposition: Updates in Genetic Testing
Kristen Zarfos, MD Linda Steinmark, MS, LCGC
Genetic Risk Assessment and Genetic Counseling Research
Mammograms and Breast Exams: When to start /stop mammograms
Breast Cancer Screening/Imaging
Surgical Management of the Breast in Breast Cancer
Hereditary Gastrointestinal Cancers
Genomics and Genetic Testing
From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med. 2013;159(10):
Breast cancer screening recommendations
Figure 1. (A) Cumulative risk of breast (diamonds) and ovarian (squares) cancer in BRCA1 mutation carriers. (B) Cumulative risk of breast (diamonds) and.
Family Tree Presentation
Tobacco Cessation Coverage
Breast Screening and Risk Assessment
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
HCV Infection in the United States: What Are We Dealing With?
Counseling Patients About Germline BRCA Mutations
US Preventive Services Task Force. Ann Intern Med 2009;150:
The Affordable Care Act (ACA) and Public Health
Stamatia Destounis, MD, FACR, FSBI, FAIUM
The decision tree with the two alternatives.
Specific Tumor Suppressor Genes
Diagnosis of breast cancer in women age 40 and younger: Delays in diagnosis result from underuse of genetic testing and breast imaging 95% of patients.
INTEGRATED CARE MANAGEMENT AND QUALITY IMPROVEMENT
INTEGRATED CARE MANAGEMENT AND QUALITY IMPROVEMENT
Cases of and deaths from cervical cancer, with associated incidence and mortality (rates per women), among Canadian women (2002–2006) by age group.
Presentation transcript:

Research Brief: Genetic Testing for Hereditary Cancers Craig Morse BIO 101 SNHU

Expanding the Affordable Care Act’s Requirements to Cover Genetic Testing for Those Already Diagnosed with Cancer.

Summary

History: 2005 – USPSTF provided grade “B” recommendation for BRCA testing to select group of women. ACA mandates recommendations grade “A” or “B” by USPSTF must be covered without cost-sharing CONCERN: This recommendation does not include women who have already been diagnosed with breast and/or ovarian cancer.

What is BRCA? BRCA1 and BRCA2 Up to 87% lifetime risk for breast cancer A 40-60% risk for a second primary breast cancer Up to a 45% lifetime risk for ovarian cancer Identify individual = changes to medical management Incidence of mutation carriers = 1:400

Issues

Issue The ACA’s benefit for BRCA testing does not include women who have been diagnosed with breast and / or ovarian cancer. ASCO NCCN ACMG 2013 USPSTF – “out of their scope”

Recommendations

Recommendation The U.S. government should expand the Affordable Care Act to include coverage for BRCA genetic testing in women who have already had a diagnosis of breast or ovarian cancer. Like the coverage for those meeting USPSTF guidelines, this coverage should exclude cost-sharing.

Reasoning

Arguments For Preventing a new diagnosis is more cost-effective than treating it Reduce mortality Arguments Against Genetic Testing is Costly $ genetic test Prophylactic surgery Reduced imaging/follow-up Cancer diagnosis Surgery Chemotherapy Radiation Years of follow-up

Implications

Conclusions Expansion of the Affordable Care Act’s Requirements to Cover Genetic Testing to Include Those Already Diagnosed with Cancer will result in: Potential for reduction of healthcare dollars Potential for reduction in cancer incidence Potential for reduction in mortality

References Affordable Care Act Implementation FAQs – Set 12. Centers for Medicare & Medicaid Services. Available from: Sheets-and-FAQs/aca_implementation_faqs12.htmlhttp:// Sheets-and- Kroger, J. and A. Park (2013). The Angelina Effect. Time. May 27. Accessed from: Moyer, V.A. (2014). Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;160: Petrucelli N, Daly MB, Feldman GL. BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer Sep 4 [Updated 2013 Sep 26]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; Available from: U.S. Preventive Services Task Force. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement. (2005). Ann Intern Med 143: